News NEURONES

Equities

NRO

FR0004050250

Real-time Euronext Paris Other stock markets 04:36:52 2024-04-16 am EDT			5-day change	1st Jan Change
46.6 ^EUR	-0.64%		+0.43%	+6.51%

Mar. 07	Neurones: 11% growth in annual net income	CF
Mar. 06	Neurones S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neurones: 11% growth in annual net income	Mar. 07	CF
NEURONES: Net profit (group share) up 11.5% in 2023	Mar. 06	GL
NEURONES: Net profit (group share) up 11.5% in 2023	Mar. 06	AQ
Neurones S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Neurones: 11% growth in annual sales	Feb. 08	CF
NEURONES: 11.1% organic growth in 2023	Feb. 07	GL
NEURONES: Organic growth up 12.3% over the first nine months of the year	Nov. 08	GL
NEURONES: Organic growth up 12.3% over the first nine months of the year	Nov. 08	AQ
Neurones S.A. Provides Earnings Guidance for the Year 2023	Nov. 08	CI
Neurones S.A. Announces Revenue Results for the Third Quarter and Nine Months of 2023	Nov. 08	CI
NEURONES : Letter to shareholders - october 2023	23-10-17	PU
NEURONES : 8.1% net profit in 1st half 2023	23-09-06	PU
NEURONES: 8.1% net profit in 1st half 2023	23-09-06	GL
NEURONES: 8.1% net profit in 1st half 2023	23-09-06	AQ
Neurones S.A. Provides Earnings Guidance for the Full Year 2023	23-09-06	CI
Neurones S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-06	CI
NEURONES : Organic growth up 12.9% in 1st half 2023	23-08-02	PU
NEURONES: Organic growth up 12.9% in 1st half 2023	23-08-02	GL
NEURONES: Organic growth up 12.9% in 1st half 2023	23-08-02	AQ
Ex-dividend day for final dividend	23-06-13	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer